- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Shilpa Medicare Dilutes Stake in Koanna Healthcare Canada

New Delhi: Shilpa Medicare Limited's wholly owned subsidiary Koanna Healthcare Canada Inc. has ceased to be a wholly owned subsidiary following the allotment of equity shares to an individual investor.
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, through an intimation dated 15 January 2026.
In its filing, Shilpa Medicare stated that Koanna Healthcare Canada Inc., a wholly owned subsidiary of the company, on 14 January 2026, allotted 2,84,21,020 equity shares aggregating to a total consideration of CAD 2,000. The allotment was carried out pursuant to a Share Sale–Purchase Agreement in favour of Mr. Steve N. Slilaty, an individual residing in Québec, Canada.
The company clarified that it had already made provisions for the said investment in its subsidiary and, therefore, there is no impact on Shilpa Medicare Limited’s current financials arising from this transaction. Consequent to the allotment of shares, Koanna Healthcare Canada Inc. ceased to be a wholly owned subsidiary of Shilpa Medicare Limited with effect from 14 January 2026.
Shilpa Medicare further disclosed that Koanna Healthcare Canada Inc. was not a material subsidiary of the company as defined under Regulation 16 of the SEBI LODR Regulations, 2015.
As per details provided in Annexure A, the income of Koanna Healthcare Canada Inc. for the last financial year stood at ₹34.33 lakh, contributing 0.03% to the consolidated income of Shilpa Medicare Limited, while its net worth was ₹46.09 lakh, accounting for 0.02%, based on audited financial statements as on 31 March 2025.
The date of execution and completion of the sale was reported as 14 January 2026, with the company noting that the share transfer may take normal time as per regular business practices. The filing also clarified that the transaction does not fall under related party transactions, was not part of any scheme of arrangement, and does not qualify as a slump sale.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

